APA

Juang S., Lung C., Hsu P., Hsu K., Li Y., Hong P., Shiah H., Kuo C., Huang C., Wang Y., Huang L., Chen T. S., Chen S., Fu K., Hsu C., Lin M., Chang C., Ashendel C. L., Chan T. C. K., Chou K. & Chang J. (20070316). D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. : Molecular cancer therapeutics.

Chicago

Juang Shin-Hun, Lung Chia-Chi, Hsu Pi-Chen, Hsu Kuo-Shun, Li Yu-Chen, Hong Pao-Chiung, Shiah Her-Shyong, Kuo Ching-Chuan, Huang Ching-Wei, Wang Yu-Chin, Huang Leeyuan, Chen Tom S, Chen Shyh-Fong, Fu Kuo-Chu, Hsu Cheng-Li, Lin Meng-Ju, Chang Ching-Jer, Ashendel Curtis L, Chan Thomas C K, Chou Kai-Ming and Chang Jang-Yang. 20070316. D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. : Molecular cancer therapeutics.

Harvard

Juang S., Lung C., Hsu P., Hsu K., Li Y., Hong P., Shiah H., Kuo C., Huang C., Wang Y., Huang L., Chen T. S., Chen S., Fu K., Hsu C., Lin M., Chang C., Ashendel C. L., Chan T. C. K., Chou K. and Chang J. (20070316). D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. : Molecular cancer therapeutics.

MLA

Juang Shin-Hun, Lung Chia-Chi, Hsu Pi-Chen, Hsu Kuo-Shun, Li Yu-Chen, Hong Pao-Chiung, Shiah Her-Shyong, Kuo Ching-Chuan, Huang Ching-Wei, Wang Yu-Chin, Huang Leeyuan, Chen Tom S, Chen Shyh-Fong, Fu Kuo-Chu, Hsu Cheng-Li, Lin Meng-Ju, Chang Ching-Jer, Ashendel Curtis L, Chan Thomas C K, Chou Kai-Ming and Chang Jang-Yang. D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. : Molecular cancer therapeutics. 20070316.